American Association of Zoo Veterinarians Infectious Disease Committee Manual 2013 SIMIAN IMMUNODEFICIENCY VIRUSES Animal Group(s) Affected Found in many African nonhuman primates. Macaques susceptible. Transmission Clinical Signs Severity Treatment Prevention and Control Zoonotic Mainly horizontal through sexual contact and bite wounds. Clinical disease occurs in only a minority of infected individuals. Severe and fatal in nonnatural host Test collection and determine risk to benefit of introductions to naïve animals. Vertical transmission reported by virus-infected milk When pathogenic, disease depends on the nature of the organ and opportunistic infections. None specific although same treatment options for HIV could be used Infection should be considered a zoonotic disease since many SIV species can grow in human cell lines in vitro. Fact Sheet compiled by: Sam Rivera; updated by Natalie Mylniczenko Sheet completed on: 1 June 2011; updated 10 September 2013 Fact Sheet Reviewed by: William Switzer; Karen Strait Susceptible animal groups: Natural host can be susceptible to disease and older animals may succumb to AIDS-related disease. Non-natural host infections can be fatal. Asian macaques are highly susceptible to fatal infection. Causative organism: SIVagm, SIVasc, SIV bkm, SIVblu, SIVcol, SIVcpz, SIVdeb, SIVden, SIVdrl, SIVgor, SIVgsn, SIVl’hoest, SIVmnd 1 and 2, SIVmon, SIVmus, SIV olc, SIVrcm, SIVschm, SIVsmm, SIVstm, SIVsun, SIVsyk, SIVtal, SIVwrc. Zoonotic potential: The virus should be considered a zoonotic disease. Many SIV species can grow in human cell lines in vitro. HIV-1 originated from SIVcpz and SIVgor; HIV-2 from SIVsmm. Distribution: Natural infections occur in Africa. Infection in captive non-human primates occurs worldwide. Cross species viral ‘jumping’ has been reported but appears relatively rare. Incubation period: Strain and host dependent, as short as a few weeks in non-natural host or as long as several decades in natural host. Clinical signs: Clinical disease does not usually present in natural hosts. However, when disease occurs, common findings are lymphadenopathy and diarrhea. Other signs may include wasting, malabsorption, and weight loss. Cardiac disease, arteriopathies, transient cutaneous erythematous maculopapular rash, and CNS involvement can be observed. Secondary infections can be due to immunodeficiency and hypergammaglobulinemia can be observed. Post mortem, gross, or histologic findings: Lymphoid organs may be hypertrophied. Other findings depend on affected organ systems: encephalitis, cardiac necrosis, myocarditis, coronary or systemic arteriopathy, glomurulosclerosis, pneumonia, follicular hyperplasia and fragmentation in lymphoid tissues, extramedullary hematopoiesis in lymph nodes and follicular and paracortical hyperplasia, epididymitis, prostatitis, urethritis, malignant lymphomas. Diagnosis: Serology (ELISA, Western blot), PCR, virus isolation. If positive on serology, SIV genotyping is recommended to identify natural reservoirs that are often African non-human primates. Screening is typical with ELISA testing, but confirmation should be completed with Western blot or PCR. It should be noted that American Association of Zoo Veterinarians Infectious Disease Committee Manual 2013 SIMIAN IMMUNODEFICIENCY VIRUSES highly divergent SIVs may not react completely with HIV and SIVmac antigens used in commercial assays. Viral isolation efficiency is highly variable. Material required for laboratory analysis: Whole blood, serum/plasma, body fluids, tissues Relevant diagnostic laboratories: Pathogen Detection Laboratory California National Primate Research Center University of California Road 98 & Hutchison Davis, California 95616 (530) 752-8242 Fax: (530) 752-4816 [email protected] VRL-San Antonio P.O. Box 40100 7540 Louis Pasteur, Suite 200 San Antonio, Texas 78229 877-615-7275 Fax: 210-615-7771 Zoologix Inc. 9811 Owensmouth Avenue, Suite 4 Chatsworth, California 91311-3800 818-717-8880 Fax: 818-717-8881 [email protected] zoologix.com/primate/index.htm Primate Diagnostic Services Laboratory (PDSL) Washington National Primate Research Center University of Washington Seattle Washington 98195-7330 [email protected] Treatment: None Prevention and control: Identify status of animals in collection. Determine risk to benefit of maintaining a closed population in the face of population needs. Suggested disinfectant for housing facilities: 70% ethanol, formalin, 10% household bleach (sodium hypochlorite), most lipophylic detergents, quaternary ammonium chloride, and Lysol can be used. Notification: None at this time. Measures required under the Animal Disease Surveillance Plan: None at this time. Measures required for introducing animals to infected animal: Determine current status of both groups of these animals then determine risk to benefit of introducing negative individuals to positive individuals. It is important to remember that natural reservoirs of particular SIV variants exist. Conditions for restoring disease-free status after an outbreak: Life-long infection results in inability to restore disease free status. Experts who may be consulted: American Association of Zoo Veterinarians Infectious Disease Committee Manual 2013 SIMIAN IMMUNODEFICIENCY VIRUSES William M. Switzer, MPH Retrovirus Surveillance Activity Leader, Laboratory Branch Division of HIV/AIDS Prevention, NCHSTP Centers for Disease Control and Prevention 1600 Clifton Rd. Atlanta, Georgia 30333 [email protected] References: 1. http://www.primateportal.org/ Accessed 11 September 2013. 2. Ahuka-Mundeke, S., A. Ayouba, P. Mbala-Kingebeni, F. Liegeois, A. Esteban, O. Lunguya-Metila, D. Demba, G. Bilulu, V. Mbenzo-Abokome, B.-I. Inogwabini, J.-J. Muyembe-Tamfum, E. Delaporte, and M. Peeters. 2011. Novel multiplexed HIV/simian immunodeficiency virus antibody detection assay. Emerg. Infect. Dis. 17(12): 2277-86. 3. Cohen, J. 1999. AIDS virus traced to chimp subspecies. Sci. 283: 772 – 773. 4. Essex, M. 1994 Simian immunodeficiency virus in people. N. Engl. J. Med. 330: 209 -210. 5. Etienne, L., E. Nerrienet, M. LeBreton, G.T. Bibila, Y. Foupouapouognigni, D. Rousset, A. 6. Nana, C.F. Djoko, U. Tamoufe, A.F. Aghokeng, E. Mpoudi-Ngole, E. Delaporte, M. Peeters, N.D. Wolfe, and A. Ayouba. 2011. Characterization of a new simian immunodeficiency virus strain in a naturally infected Pan troglodytes troglodytes chimpanzee with AIDS related symptoms. Retrovirol. 8: 4. 7. Keele, B.F., J.H. Jones, K.A. Terio, J.D. Estes, R.S. Rudicell, M.L. Wilson, Y. Li, G.H. Learn, T.M. Beasley, J. Schumacher-Stankey, E. Wroblewski, A. Mosser, J. Raphael, S. Kamenya, E.V. Lonsdorf, D.A. Travis, T. Mlengeya, M.J. Kinsel, J.G. Else, G. Silvestri, J. Goodall, P.M. Sharp, G.M. Shaw, A.E. Pusey, and B.H. Hahn. 2009. Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpz. Nature. 460(7254): 515-519. 8. Lerche, N. W. 2005. Common viral infections of laboratory primates. In: Wolfe-Coote, S. (ed). The Handbook of Experimental Animals; The Laboratory Primate. Elsevier Academic Press, San Diego, California. Pp. 75-89. 9. Lowestine, L.J., and N.W. Lerche. 2003. Nonhuman primate retroviruses and simian acquired immunodeficiency syndrome. In: Fowler, M.E. (ed). Zoo & Wild Animal Medicine, Current Therapy 3. W.B. Saunders Co., Philadelphia, Pennsylvania. Pp. 373-378. 10. Sharp, P.M., and B.H. Hahn. 2010. The evolution of HIV-1 and the origin of AIDS. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 365(1552): 2487-2494. 11. Terio, K.A., M.J. Kinsel, J. Raphael, T. Mlengeya, I. Lipende, C.A. Kirchhoff, B. Gilagiza, M.L. Wilson, S. Kamenya, J.D. Estes, B.F. Keele, R.S. Rudicell, W. Liu, S. Patton, A. Collins, B.H. Hahn, D.A. Travis, and E.V. Lonsdorf. 2011. Pathologic lesions in chimpanzees (Pan trogylodytes schweinfurthii) from Gombe National Park, Tanzania, 2004-2010. J. Zoo Wildl. Med. 42: 597-607. 12. Voevodin, A.F., P.A. Marx, and C. Apetrei (eds.). 2009. Lentiviruses in their natural hosts Betaretroviruses. In: Simian Virology. Willey-Blackwell, Ames, Iowa. Pp. 77-118. 13. Voevodin, A.F. and P.A. Marx. 2009. Lentiviruses and their natural hosts. In: Simian Virology. Wiley Blackwell, Ames, Iowa. Pp. 77-118. 14. Weston-Murphy, H., and W.M. Switzer. 2008. Occupational exposure to zoonotic simian retroviruses: health and safety implications for persons working with nonhuman primates. In: Fowler, M.E. and R.E. Miller (eds). Zoo & Wild Animal Medicine, Current Therapy 6. Saunders/Elsevier, St. Louis, Missouri. Pp. 251-264. 15. Whetter, L.E., I.C. Ojukwu, F.J. Novembre, and S. Dewhurst. 1999. Pathogenesis of simian American Association of Zoo Veterinarians Infectious Disease Committee Manual 2013 SIMIAN IMMUNODEFICIENCY VIRUSES immunodeficiency virus infection. J. Gen. Vir. 80: 1557–1568.
© Copyright 2018